Eva Griesser
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eva Griesser has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Angus I. Lamond
Division of Molecular Cell and Developmental Biology, School of Life Sciences, University of Dundee
1 shared publication - Birgit Stierstorfer
Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany
1 shared publication - Carolin Kirsten Watson
Immunology & Respiratory Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
1 shared publication Daniel Veyel
Drug Discovery Sciences Boehringer Ingelheim Pharma GmbH & Co. KG Biberach an der Riß Germany
1 shared publication- Daniela Schloesser
Department of Immunology and Respiratory Disease Research, Boehringer Ingelheim Pharma GmbH & Co. KG, 88397 Biberach an der Riss, Germany
1 shared publication - Frederik H. Igney
Boehringer Ingelheim Pharma GmbH & Co. KG Discovery Research
1 shared publication
Latest Publications
- 26 January 2023
- Published by Wiley in Proteomics
- Vol. 23 (10) , e2100414
Whole lung proteome of an acute epithelial injury mouse model in comparison to spatially resolved proteomes
Epithelial injury is one of the major drivers of acute pulmonary diseases. Recurring injury followed by aberrant repair is considered as the primary cause of chronic lung diseases, such as idiopathic pulmonary fibrosis (IPF). Preclinical in vivo models allow studying early disease‐driving mechanisms like the recently established adeno‐associated virus‐diphtheria toxin receptor (AAV‐DTR) mouse model of acute epithelial lung injury, which utilises AAV mediated expression of the human DTR. We performed quantitative proteomics of homogenised lung samples from this model and compared the results to spatially resolved proteomics data of epithelial cell regions from the same animals. In whole lung tissue proteins involved in cGAS‐STING and interferon pathways, proliferation, DNA replication and the composition of the provisional extracellular matrix were upregulated upon injury. Besides epithelial cell markers SP‐A, SP‐C and Scgb1a1, proteins involved in cilium assembly, lipid metabolism and redox pathways were among downregulated proteins.Comparison of the bulk to spatially resolved proteomics data revealed a large overlap of protein changes and striking differences. Together our study underpins the broad usability of bulk proteomics and pinpoints to the benefit of sophisticated proteomic analyses of specific tissue regions or single cell types.
- 26 January 2023
- Published by Wiley in Proteomics
- Vol. 23 (10) , e2100414
Whole lung proteome of an acute epithelial injury mouse model in comparison to spatially resolved proteomes
Epithelial injury is one of the major drivers of acute pulmonary diseases. Recurring injury followed by aberrant repair is considered as the primary cause of chronic lung diseases, such as idiopathic pulmonary fibrosis (IPF). Preclinical in vivo models allow studying early disease‐driving mechanisms like the recently established adeno‐associated virus‐diphtheria toxin receptor (AAV‐DTR) mouse model of acute epithelial lung injury, which utilises AAV mediated expression of the human DTR. We performed quantitative proteomics of homogenised lung samples from this model and compared the results to spatially resolved proteomics data of epithelial cell regions from the same animals. In whole lung tissue proteins involved in cGAS‐STING and interferon pathways, proliferation, DNA replication and the composition of the provisional extracellular matrix were upregulated upon injury. Besides epithelial cell markers SP‐A, SP‐C and Scgb1a1, proteins involved in cilium assembly, lipid metabolism and redox pathways were among downregulated proteins.Comparison of the bulk to spatially resolved proteomics data revealed a large overlap of protein changes and striking differences. Together our study underpins the broad usability of bulk proteomics and pinpoints to the benefit of sophisticated proteomic analyses of specific tissue regions or single cell types.
- Open Access
- 2 December 2022
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 222 (2)
Senescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT/L axis
Progressive accrual of senescent cells in aging and chronic diseases is associated with detrimental effects in tissue homeostasis. We found that senescent fibroblasts and epithelia were not only refractory to macrophage-mediated engulfment and removal, but they also paralyzed the ability of macrophages to remove bystander apoptotic corpses. Senescent cell-mediated efferocytosis suppression (SCES) was independent of the senescence-associated secretory phenotype (SASP) but instead required direct contact between macrophages and senescent cells. SCES involved augmented senescent cell expression of CD47 coinciding with increased CD47-modifying enzymes QPCT/L. SCES was reversible by interfering with the SIRPα-CD47-SHP-1 axis or QPCT/L activity. While CD47 expression increased in human and mouse senescent cells in vitro and in vivo, another ITIM-containing protein, CD24, contributed to SCES specifically in human epithelial senescent cells where it compensated for genetic deficiency in CD47. Thus, CD47 and CD24 link the pathogenic effects of senescent cells to homeostatic macrophage functions, such as efferocytosis, which we hypothesize must occur efficiently to maintain tissue homeostasis.
- 2 December 2022
- Published by Rockefeller University Press in Journal of Cell Biology
- Vol. 222 (2)
Open AccessSenescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT/L axis
Progressive accrual of senescent cells in aging and chronic diseases is associated with detrimental effects in tissue homeostasis. We found that senescent fibroblasts and epithelia were not only refractory to macrophage-mediated engulfment and removal, but they also paralyzed the ability of macrophages to remove bystander apoptotic corpses. Senescent cell-mediated efferocytosis suppression (SCES) was independent of the senescence-associated secretory phenotype (SASP) but instead required direct contact between macrophages and senescent cells. SCES involved augmented senescent cell expression of CD47 coinciding with increased CD47-modifying enzymes QPCT/L. SCES was reversible by interfering with the SIRPα-CD47-SHP-1 axis or QPCT/L activity. While CD47 expression increased in human and mouse senescent cells in vitro and in vivo, another ITIM-containing protein, CD24, contributed to SCES specifically in human epithelial senescent cells where it compensated for genetic deficiency in CD47. Thus, CD47 and CD24 link the pathogenic effects of senescent cells to homeostatic macrophage functions, such as efferocytosis, which we hypothesize must occur efficiently to maintain tissue homeostasis.
- Open Access
- 1 May 2020
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 19 (5) , 839-851
Quantitative Profiling of the Human Substantia Nigra Proteome from Laser-capture Microdissected FFPE Tissue
- 1 May 2020
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 19 (5) , 839-851
Open AccessQuantitative Profiling of the Human Substantia Nigra Proteome from Laser-capture Microdissected FFPE Tissue